Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
| Federal Circuit U.S. Court of Appeals | |
| Case #: | 0:24-cvpri-02002 |
| Type | civil private |
| Nature of Suit | 830 Property Rights - Patent |
| Case Filed: | Jun 25, 2024 |
| Last checked: Wednesday Jun 26, 2024 5:18 AM EDT |
|
Defendant
AMGEN USA, INC.
|
|
|
Defendant
CELLTRION, INC.
|
|
|
Defendant
SAMSUNG BIOEPIS CO., LTD.
|
|
|
Defendant
FORMYCON AG
|
|
|
Defendant
AMGEN INC.
|
|
|
Defendant - Appellant
MYLAN PHARMACEUTICALS INC.
|
Represented By
|
|
Defendant - Appellant
BIOCON BIOLOGICS INC.
|
Represented By
|
|
Plaintiff - Appellee
REGENERON PHARMACEUTICALS, INC.
|
Represented By
|
| Docket last updated: 06/26/2024 4:30 AM EDT |
| Tuesday, June 25, 2024 | ||
| 1 | 1 Appeal docketed. Received: 06/21/2024. [1013376] Entry of Appearance is due on 07/09/2024. Certificate of Interest is due on 07/09/2024. Docketing Statement is due on 07/09/2024. Appellants' brief is due on 08/26/2024. [JSP] [Entered: 06/25/2024 02:59 PM] | |
Att: 1
4 pgs
Notice of Docketing
|
||
|
Att: 2
65 pgs
Civil Case Docketed
|
||